Skip to main content
Earnings Labs
Virax Biolabs Group Limited logo

Virax Biolabs Group Limited (VRAX)

NASDAQ·Healthcare·Biotechnology

$2.94

-0.17%

Mkt Cap $868.39K

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$1.00

Range $1.00$1.00

Implied Upside

-65.9%

Consensus $1.00 vs current $2.94